Replies to post #23 on Relevium Technologies, Inc (RLLVF)

[JohnCM]

Relevium Continues to Execute

July 24th 2018 - Technical420

Last week, Relevium’s (RLV) (RLLVF) wholly-owned subsidiary Biocannabix (BCX) received an approval letter from the City of Ville St-Laurent (VSL), located in Montréal, Québec. This is a milestone and we are monitoring how the team executes from here. Last month, BCX selected a 93,000 sq. ft. facility in Montreal to cultivate premium organic cannabis

The company intends to develop the project in stages and expects to retrofit the building with an initial phase of 10,000 sq. ft. of cultivation. Upon the completion of the first stage, successful operations and licensing, the company will then proceed with phases 2 and 3. Construction of the project is subject to financing and customary approvals.

The market responded favorably to the approval letter and we are monitoring how the shares trade from here. Relevium’s strategy is to cultivate high quality organic strains for use in exclusive, high-end consumer packaged goods primarily for health and wellness. The company does not plan to be a large scale producer and is focused on custom niche and organic products with established partnerships for processing and ongoing research in cannabis derivatives.

The market for high-end products is significant and are favorable on this opportunity. If BCX can create market share and develop brands that resonate with high-end consumers, this can be a significant growth driver. With Canada’s recreational market set to open, it will be interesting to see how the market develops. We expect to see several types of consumers and expect the high-end side of the market to be massive.

Relevium represents a differentiated opportunity and we are monitoring how the company continues to execute. When compared to other late stage ACMPR applicants, Relevium is undervalued and underappreciated. This is a company to keep an eye on!